HER2CAR-armed CD8+ T cells efficiently recognized and killed the tumor cells, even in the absence of MHC-class I, and regardless of the HLA-class I haplotype (Figure 5(c) and Figure S4c). This evidence concerns the gene CD8A and neoplasm.